MyMD Pharmaceuticals, Inc. 

MD

  SEC # 1321834

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Relationships

        

No  Owner Relationships  (where the Issuers of the  MyMD Pharmaceuticals, Inc.-owned  securities are...)

        

First  20  of  59  Issuer Relationships  (where the Owners of the  MyMD Pharmaceuticals, Inc.  securities are...)

First		Latest Filing		Filing		Filer / Owner
		2/14/24		SC 13G		NY	Global X Management Co. LLC
12/18/19		2/14/24		SC 13G		NY	Iroquois Capital Management, LLC
4/20/21		8/24/23		4		NY	Rivard Paul
4/21/21		6/9/23		4		MD	Chapman Christopher C Jr.
4/22/21		6/9/23		4		NY	Eagle Craig
4/21/21		6/9/23		4		NY	Kaplin Adam
4/2/19		6/9/23		4		NJ	Schreiber Christopher C
4/2/19		6/9/23		4		NY	Silverman Joshua
4/21/21		6/9/23		4		NY	Uzonwanne Jude
4/2/19		6/9/23		4		WA	White Billy Joe
		9/8/22		SC 13D		FL	Duffey Samuel S
12/19/19		2/11/22		SC 13G		FL	Intracoastal Capital, LLC
2/18/21		1/11/22		SC 13G		NY	Mainfield Enterprises Inc.
		4/27/21		SC 13D		FL	Williams Caroline C
		4/26/21		3			"
		4/22/21		3		NY	Eagle Craig
		4/21/21		3		MD	Chapman Christopher C Jr.
		4/21/21		3		NY	Kaplin Adam
		4/21/21		3		NY	Uzonwanne Jude
		4/20/21		3		NY	Rivard Paul
→Please Sign In to List all of them.

List all Money Managers that own this Security Issuer:  CUSIP 62856X

        

First  20  of  34  Insider & Control Relationships  (Directors & Officers, Owners, Parent / Subs., et al.)

First		Latest Filing		Relationship		Registrant
6/9/23		8/24/23		Officer:  Chief Legal Officer		NY	Rivard Paul
4/21/21		6/9/23		Director		MD	Chapman Christopher C Jr.
4/21/21		6/9/23		Officer:  President, Chief Med. Officer			"
4/22/21		6/9/23		Director		NY	Eagle Craig
4/21/21		6/9/23		Officer:  Chief Scientific Officer		NY	Kaplin Adam
9/21/18		6/9/23		Director		NJ	Schreiber Christopher C
9/20/18		6/9/23		Director		NY	Silverman Joshua
4/21/21		6/9/23		Director		NY	Uzonwanne Jude
4/10/18		6/9/23		Director		WA	White Billy Joe
4/20/21		12/8/22		Officer:  EVP of Operations, GC		NY	Rivard Paul
		4/26/21		10% Owner		FL	Williams Caroline C
11/7/19		4/20/21		Director		NY	Schroeder Robert C
		2/11/21		Officer:  Interim CFO		CT	Rhodes Ian
		9/11/20		Officer:  Exec. Chairman & President		NJ	Schreiber Christopher C
		8/31/20		Officer:  Chief Financial Officer		NY	Benson Stuart M
1/7/20		3/3/20		10% Owner		CT	Gerber Sander
1/7/20		3/3/20		10% Owner		CT	Hudson Bay Capital Management LP
		1/3/20		Officer:  Executive Chairman		NJ	Schreiber Christopher C
10/16/18		10/3/19		Officer:  CEO, CFO		NJ	Yeaton Howard
10/24/17		4/10/18		Director		NJ	Gormally John J
→Please Sign In to List all of them.

        

No  Joint-Filer Relationships  (Co-Filer Registrants:  Partners, Affiliates, et al.)

        

No  Group-Member Relationships  (Co-Filer Non-Registrants:  Partners, Affiliates, et al.)

        

Filing Agent Relationships  (SEC Filing Agents, Attorneys, Printers, et al. — Affiliates:  Directors & Officers, et al.)

5  Filing Agents and/or Registrants have submitted Filings for  MyMD Pharmaceuticals, Inc.:

Latest Filing				Filing Agentª, Registrant or SEC — SEC #			Filings
		Type
4/18/24		8-K		FL	M2 Compliance LLC/FA — 1493152		279
5/12/21		EFFECT			No Filing Agent:  SEC-filed by SEC #5 — 9999999995		10
12/20/17		424B4		NY	EdgarAgents LLC/FA — 1213900		17
1/9/15		8-K		NY	Toppan Merrill/FA — 1144204		23
1/23/14		CERTNAS			No Filing Agent:  SEC-filed by SEC #7 — 9999999997		3
Total:							332
__________  ª  Proprietary to SEC Info℠:  The SEC does not publish the names of SEC Filing Agents.